Results 141 to 150 of about 127,771 (308)

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

A Unifying Impossibility Theorem [PDF]

open access: yes
This paper considers social choice correspondences assigning a choice set to each non-empty subset of social alternatives. We impose three requirements on these correspondences: unanimity, independence of preferences over infeasible alternatives and ...
Shino Takayama, Priscilla Man
core  

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

Framing for incentive compatibility in choice modelling

open access: yes
The incentives that motivate respondents to reveal their preferences truthfully have been a long-standing area of research in the non-market valuation literature.
Mazur, Kasia, Bennett, Jeffrey W.
core  

The cognitive perspective in strategic choice [PDF]

open access: yes, 2018
This paper examines to what degree organizations use strategies that focus on maximizing shareholder value (Theory E) or if they use strategies emphasizing the development of organizational capability (Theory O).
Selart, Marcus, Midtgård, Kenneth
core  

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

open access: yesMolecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic   +5 more
wiley   +1 more source

Strengthening the strategic choice offered to the EU’s southern Mediterranean neighbours. CEPS Commentary, 1 February 2013

open access: yes, 2013
Finding that the European Neighbourhood Policy (ENP) currently lacks a strategic vision that would offer states in the southern Mediterranean substantial returns in exchange for making tough reforms, this CEPS Commentary suggests that this weakness can ...
Van Vooren, Bart, Blockmans, Steven.
core  

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

open access: yesMolecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric   +10 more
wiley   +1 more source

Competition and the Strategic Choice of Managerial Incentives: the Relative Performance Case

open access: yes
In this paper we study the role of market competitiveness in a strategic delegation game in which owners delegate output decisions to managers interested in the firm's relative performance.
Chirco, Alessandra   +2 more
core  

Methods to Identify Strategic Alternatives of Development of the Organization

open access: yesУправленческое консультирование, 2018
Modern methodological support of the strategic management of the company offers a wide range of methods to identify possible areas of development of the organization. There are two approaches: marketing for the development of the product, and management,
Juriy Mikhailovich Tsygalov   +1 more
doaj  

Home - About - Disclaimer - Privacy